Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan in Atrial Functional Mitral Regurgitation
NCT07539298Phase 3Recruiting
- Start
- Jul 2026
- Primary completion
- May 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of valsartan in atrial functional mitral regurgitation (AFMR). Started Jul 2026; status: recruiting.
02
Drugs
valsartan
03
Conditions
atrial functional mitral regurgitation (AFMR)
Beyond the preview
Go deeper on NCT07539298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07539298.